UBS Group’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.09M Sell
483,980
-95,416
-16% -$609K ﹤0.01% 3460
2025
Q1
$2.82M Sell
579,396
-10,825
-2% -$52.6K ﹤0.01% 3452
2024
Q4
$5.64M Buy
590,221
+321,783
+120% +$3.08M ﹤0.01% 2872
2024
Q3
$2.24M Buy
268,438
+11,480
+4% +$95.9K ﹤0.01% 2935
2024
Q2
$1.75M Sell
256,958
-29,081
-10% -$198K ﹤0.01% 2959
2024
Q1
$724K Buy
286,039
+82,879
+41% +$210K ﹤0.01% 3801
2023
Q4
$488K Buy
203,160
+113,993
+128% +$274K ﹤0.01% 3996
2023
Q3
$303K Sell
89,167
-120,384
-57% -$409K ﹤0.01% 3967
2023
Q2
$1.54M Sell
209,551
-35,027
-14% -$257K ﹤0.01% 2914
2023
Q1
$2.53M Buy
244,578
+36,606
+18% +$379K ﹤0.01% 2381
2022
Q4
$2.46M Buy
207,972
+121,190
+140% +$1.43M ﹤0.01% 2401
2022
Q3
$1.82M Buy
86,782
+15,642
+22% +$328K ﹤0.01% 2421
2022
Q2
$2.21M Sell
71,140
-723
-1% -$22.4K ﹤0.01% 2324
2022
Q1
$2.95M Sell
71,863
-85,131
-54% -$3.5M ﹤0.01% 2359
2021
Q4
$6.82M Buy
156,994
+69,694
+80% +$3.03M ﹤0.01% 1839
2021
Q3
$4.37M Buy
87,300
+56,468
+183% +$2.83M ﹤0.01% 2124
2021
Q2
$1.94M Sell
30,832
-24,194
-44% -$1.52M ﹤0.01% 2756
2021
Q1
$5.11M Buy
55,026
+20,793
+61% +$1.93M ﹤0.01% 1934
2020
Q4
$3.07M Sell
34,233
-22,332
-39% -$2M ﹤0.01% 2255
2020
Q3
$5.84M Sell
56,565
-11,449
-17% -$1.18M ﹤0.01% 1598
2020
Q2
$5.38M Buy
68,014
+53,829
+379% +$4.26M ﹤0.01% 1556
2020
Q1
$820K Sell
14,185
-45,648
-76% -$2.64M ﹤0.01% 2819
2019
Q4
$3.23M Sell
59,833
-53,744
-47% -$2.9M ﹤0.01% 2365
2019
Q3
$5.94M Buy
113,577
+86,105
+313% +$4.5M ﹤0.01% 1719
2019
Q2
$1.33M Sell
27,472
-13,524
-33% -$654K ﹤0.01% 2824
2019
Q1
$2.07M Sell
40,996
-43,816
-52% -$2.21M ﹤0.01% 2404
2018
Q4
$5.03M Buy
84,812
+45,802
+117% +$2.72M ﹤0.01% 1696
2018
Q3
$2.57M Buy
39,010
+12,153
+45% +$800K ﹤0.01% 2430
2018
Q2
$1.36M Sell
26,857
-53,164
-66% -$2.68M ﹤0.01% 2835
2018
Q1
$4.21M Buy
80,021
+51,895
+185% +$2.73M ﹤0.01% 1982
2017
Q4
$1.31M Sell
28,126
-805
-3% -$37.4K ﹤0.01% 2824
2017
Q3
$1.17M Buy
28,931
+10,503
+57% +$425K ﹤0.01% 2884
2017
Q2
$626K Sell
18,428
-15,245
-45% -$518K ﹤0.01% 3216
2017
Q1
$978K Sell
33,673
-2,385
-7% -$69.3K ﹤0.01% 2851
2016
Q4
$1.19M Buy
36,058
+12,146
+51% +$399K ﹤0.01% 2698
2016
Q3
$754K Sell
23,912
-5,861
-20% -$185K ﹤0.01% 2892
2016
Q2
$837K Buy
29,773
+16,254
+120% +$457K ﹤0.01% 2834
2016
Q1
$492K Sell
13,519
-1,342
-9% -$48.8K ﹤0.01% 3136
2015
Q4
$595K Buy
14,861
+5,354
+56% +$214K ﹤0.01% 3032
2015
Q3
$271K Sell
9,507
-4,763
-33% -$136K ﹤0.01% 3507
2015
Q2
$470K Buy
14,270
+8,148
+133% +$268K ﹤0.01% 3311
2015
Q1
$176K Buy
6,122
+5,384
+730% +$155K ﹤0.01% 3868
2014
Q4
$20K Buy
+738
New +$20K ﹤0.01% 5544